Symbiotec Pharmalab IPO Live Subscription Status
Real-time subscription data from BSE & NSE with category-wise breakdowns
📈 Building steadily
📈 GMP Today
🎟️ Allotment Status
📄 Full IPO Details
Listed at BSE & NSE · Registrar: MUFG Intime India Pvt. Ltd.
Price: ₹938 - ₹988
Lot: 15
Min: ₹14,820
Period: 24 Aug - 27 Aug
Subscribed
75.05x
Total Demand
₹92,398 Cr
Applications
—
Subscription (Shares)
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 35,50,608 | 64,33,59,195 | 181.20 |
| NII | 26,62,955 | 20,65,31,340 | 77.56 |
| bNII (>10 Lakh) | 17,75,304 | 15,50,46,495 | 87.34 |
| sNII (2-10 Lakh) | 8,87,651 | 5,14,84,845 | 58.00 |
| Retail | 62,13,562 | 8,47,65,465 | 13.64 |
| Employee Reserved | 33,408 | 5,44,845 | 16.31 |
| TOTAL | 1,24,60,533 | 93,52,00,845 | 75.05 |
Application Breakup
| Category | Reserved | Applications | Times |
|---|---|---|---|
| NII | 12,681 | 9,83,483 | 77.56 |
| bNII (>10 Lakh) | 8,454 | 1,52,006 | 17.98 |
| sNII (2-10 Lakh) | 4,227 | 2,45,166 | 58.00 |
| Retail | 4,14,237 | 56,51,031 | 13.64 |
| Employee Reserved | 2,227 | 36,323 | 16.31 |
| TOTAL | 4,41,826 | 70,68,009 | 16.00 |
Subscription (Crores)
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIB | 350.80 | 63,563.89 | 181.20 |
| NII | 263.10 | 20,405.30 | 77.56 |
| bNII (>10 Lakh) | 175.40 | 15,318.59 | 87.34 |
| sNII (2-10 Lakh) | 87.70 | 5,086.70 | 58.00 |
| Retail | 613.90 | 8,374.83 | 13.64 |
| Employee Reserved | 3.30 | 53.83 | 16.31 |
| TOTAL | 1,231.10 | 92,397.84 | 75.05 |
Subscription by Category
1× = fully subscribed · capped 10×
Estimated Allotment Chance
Retail
8.4%
(13.64x subscribed)
Low chance
S-HNI (2-10L)
1.7%
(58.00x subscribed)
Low chance
B-HNI (>10L)
5.6%
(87.34x subscribed)
Low chance
Employee
6.1%
(16.31x subscribed)
Low chance
If 100 retail investors apply, approximately 8 will get allotment.
Estimated from current subscription data, calibrated against published basis-of-allotment results.
Actual allotment depends on the number of applications received and SEBI's allotment rules —
draw of lots for Retail, Employee and NII; proportionate for QIB.
Disclaimer: Subscription data is sourced from BSE and NSE.
Please verify with official exchange websites before making any investment decisions.
This information is for educational purposes only and should not be construed as investment advice.
Symbiotec Pharmalab IPO Subscription — Detailed Analysis
Where Symbiotec Pharmalab Subscription Stands Today
Symbiotec Pharmalab IPO has been subscribed 75.05 times overall — a heavily oversubscribed level that signals strong investor demand and improves the prospects of a positive listing day.
Symbiotec Pharmalab IPO Subscription — FAQs
Symbiotec Pharmalab IPO is currently subscribed 75.05 times overall.
Symbiotec Pharmalab IPO is open for subscription from August 24, 2026 to August 27, 2026.
The price band for Symbiotec Pharmalab IPO is ₹938 - ₹988 per share.
New to subscription data? The hub explains what QIB, NII and Retail mean and how to read the table. For allotment odds from these numbers, see the allotment chances calculator or our IPO allotment process explainer.
Explore More
Quick links to all IPO sections
Open IPO
Live now
Best IPO Today
Top picks
Upcoming IPO
Coming soon
IPO Calendar
Dates & schedule
Closed IPO
Allotment pending
Listed IPO
Listing gains
IPO GMP
Grey market premium
Subscription
Live bidding data
Allotment
Check status
SME IPO
Small & medium
Mainboard IPO
Large cap
Performance
Listing returns
Learn
IPO guides